Reversible acylation and inhibition of aggregation of platelets by substituted maleic anhydrides.
D000215:Acylation; D000244:Adenosine Diphosphate / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005663:Furans / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008299:Maleic Anhydrides / Q000031:analogs & derivatives / Q000494:pharmacology*; D006899:Mixed Function Oxygenases / Q000097:blood*; D009391:Nephelometry and Turbidimetry; D010974:Platelet Aggregation / Q000187:drug effects*; D011451:Prostaglandin-Endoperoxide Synthases / Q000097:blood*; D013997:Time Factors
D005663:Furans; D008299:Maleic Anhydrides; D000244:Adenosine Diphosphate; D006899:Mixed Function Oxygenases; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin; D004837:Epinephrine